retatrutide nonalcoholic fatty liver disease nash trial Retatrutide may be promising for liver fat because it targets appetite, weight loss, glucose control, and metabolic health at once. But “nearly clinical” still means not a guaranteed treatment, so liver labs,

Compounded GLP 1 Drugs and its Legally Murky Advertisements Fourteen East The real power of GLP 1s comes from understanding that there is no one size fits all approach to nourishing the body, preserving strength, or maintaining progress over time. That's where nutrition and dietetics professionals come A New Use for Wegovy Opens the Door to Medicare Coverage for Millions of People with Obesity KFF GLP 1 therapies are changing obesity care. What does WHO recommend? Here's what you need to know. Hims & Hers stock surges as Novo Nordisk says it will distribute weight loss drugs on platform Low Incidence of Pulmonary Aspiration During Upper Endoscopy in Patients Prescribed a Glucagon Like Peptide 1 Receptor Agonist Clinical Gastroenterology and Hepatology